Literature DB >> 18373423

Synthesis of superparamagnetic nanotubes as MRI contrast agents and for cell labeling.

Xia Bai1, Sang Jun Son, Shixiong Zhang, Wei Liu, Elaine K Jordan, Joseph A Frank, Thirumalai Venkatesan, Sang Bok Lee.   

Abstract

AIMS: Magnetic nanoparticles have been studied widely as MRI contrast agents to increase the sensitivity of this technique. This work describes the synthesis and characterization of magnetic nanotubes (MNTs) as a novel MRI contrast agent.
METHODS: MNTs with high saturation magnetization were fabricated by the synthesis of superparamagnetic iron oxide nanoparticles (SPIONs) directly in the pores of silica nanotubes (SNTs). The MNTs were characterized by electron microscopy, superconducting quantum interference device and MRI. Preliminary studies on in vitro cytotoxicity and cell labeling were carried out.
RESULTS: The MNTs retained the superparamagnetic characteristics in bulk solutions with a considerably high saturation magnetization of 95 emu/gFe. The nuclear magnetic resonance (NMR) relaxivities for MNTs of 500 nm in length and of 60 nm in diameter were r(1) = 1.6 +/- 0.3 mM(-1)s(-1) and r(2) = 264 +/- 56 mM(-1)s(-1) and, for the MNTs of 2 microm in length and 70 nm in diameter, the r(1) and r(2) were 3.0 +/- 1.3 and 358 +/- 65 mM(-1)s(-1), respectively. In vitro cell labeling showed promising results with excellent labeling efficiency. No cellular toxicity was observed in vitro.
CONCLUSIONS: The integration of SPIONs with SNTs imparts the superparamagnetic characteristics of SPIONs onto the SNTs, creating unique magnetic nanoparticles with multifunctionality. The MNTs showed promising results as a MRI contrast agent with high NMR relaxivities, little cytotoxicity and high cell-labeling efficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373423     DOI: 10.2217/17435889.3.2.163

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  11 in total

1.  Multiwall carbon nanotubes as MRI contrast agents for tracking stem cells.

Authors:  Orazio Vittorio; Suzanne L Duce; Andrea Pietrabissa; Alfred Cuschieri
Journal:  Nanotechnology       Date:  2011-01-27       Impact factor: 3.874

Review 2.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

3.  Shape-coded silica nanotubes for multiplexed bioassay: rapid and reliable magnetic decoding protocols.

Authors:  Bo He; Sung Kyoung Kim; Sang Jun Son; Sang Bok Lee
Journal:  Nanomedicine (Lond)       Date:  2010-01       Impact factor: 5.307

4.  Nanodetoxification: emerging role of nanomaterials in drug intoxication treatment.

Authors:  Lauren M Graham; Thao M Nguyen; Sang Bok Lee
Journal:  Nanomedicine (Lond)       Date:  2011-07       Impact factor: 5.307

5.  Experimental considerations on the cytotoxicity of nanoparticles.

Authors:  Bokyung Kong; Ji Hyun Seog; Lauren M Graham; Sang Bok Lee
Journal:  Nanomedicine (Lond)       Date:  2011-07       Impact factor: 5.307

6.  Application of Higher Density Iron Oxide Nanoparticle Pellicles to Enrich the Plasma Membrane and Its Proteome from Cells in Suspension.

Authors:  Rebecca L Rose; Waeowalee Choksawangkarn; Catherine Fenselau
Journal:  Methods Mol Biol       Date:  2018

7.  Peptide-based systems analysis of inflammation induced myeloid-derived suppressor cells reveals diverse signaling pathways.

Authors:  Waeowalee Choksawangkarn; Lauren M Graham; Meghan Burke; Sang Bok Lee; Suzanne Ostrand-Rosenberg; Catherine Fenselau; Nathan J Edwards
Journal:  Proteomics       Date:  2016-07       Impact factor: 3.984

8.  Enrichment of plasma membrane proteins using nanoparticle pellicles: comparison between silica and higher density nanoparticles.

Authors:  Waeowalee Choksawangkarn; Sung-Kyoung Kim; Joe R Cannon; Nathan J Edwards; Sang Bok Lee; Catherine Fenselau
Journal:  J Proteome Res       Date:  2013-01-31       Impact factor: 4.466

9.  Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI.

Authors:  J Lodhia; G Mandarano; Nj Ferris; P Eu; Sf Cowell
Journal:  Biomed Imaging Interv J       Date:  2010-04-01

10.  Amalgamation of complex iron(III) ions and iron nanoclusters with MWCNTs as a route to potential T2 MRI contrast agents.

Authors:  Nikodem Kuźnik; Mateusz M Tomczyk; Marzena Wyskocka; Łukasz Przypis; Artur P Herman; Rafał Jędrysiak; Krzysztof K Koziol; Sławomir Boncel
Journal:  Int J Nanomedicine       Date:  2015-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.